These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 20076856)

  • 21. G-CSF during large field radiotherapy reduces bone marrow recovery capacity.
    Pape H; Orth K; Heese A; Heyll A; Kobbe G; Schmitt G; Niederbichler AD; Peiper M; Schwarz A; Boelke E
    Eur J Med Res; 2006 Aug; 11(8):322-8. PubMed ID: 17052967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enumeration of bone marrow 'homing' haemopoietic stem cells from G-CSF-mobilised normal donors and influence on engraftment following allogeneic transplantation.
    Spencer A; Jackson J; Baulch-Brown C
    Bone Marrow Transplant; 2001 Dec; 28(11):1019-22. PubMed ID: 11781610
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endogenous G-CSF and CD34+ cell mobilization after acute myocardial infarction.
    Leone AM; Rutella S; Bonanno G; Contemi AM; de Ritis DG; Giannico MB; Rebuzzi AG; Leone G; Crea F
    Int J Cardiol; 2006 Aug; 111(2):202-8. PubMed ID: 16051386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel anti-inflammatory function of human galectin-1: inhibition of hematopoietic progenitor cell mobilization.
    Kiss J; Kunstár A; Fajka-Boja R; Dudics V; Tóvári J; Légrádi A; Monostori E; Uher F
    Exp Hematol; 2007 Feb; 35(2):305-13. PubMed ID: 17258079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. G-CSF in patients suffering from late revascularized ST elevation myocardial infarction: analysis on the timing of G-CSF administration.
    Engelmann MG; Theiss HD; Theiss C; Huber A; Wintersperger BJ; Werle-Ruedinger AE; Schoenberg SO; Steinbeck G; Franz WM
    Exp Hematol; 2008 Jun; 36(6):703-9. PubMed ID: 18346835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The follow-up of the mobilization of circulating hematopoietic progenitor cells by granulocyte growth factor (G-CSF) using flow cytometry].
    De Arriba F; Ortuño F; Rivera J; Heras I; Funes C; Moraleda JM; Vicente V
    Med Clin (Barc); 1995 Jan; 104(2):41-4. PubMed ID: 7532770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
    Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
    Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human hematopoietic stem/progenitor-enriched CD34(+) cells are mobilized into peripheral blood during stress related to ischemic stroke or acute myocardial infarction.
    Paczkowska E; Larysz B; Rzeuski R; Karbicka A; Jałowiński R; Kornacewicz-Jach Z; Ratajczak MZ; Machaliński B
    Eur J Haematol; 2005 Dec; 75(6):461-7. PubMed ID: 16313257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. G-CSF therapy with mobilization of bone marrow stem cells for myocardial recovery after acute myocardial infarction--a relevant treatment?
    Ripa RS; Kastrup J
    Exp Hematol; 2008 Jun; 36(6):681-6. PubMed ID: 18358590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Granulocyte colony-stimulating factor and lineage-independent modulation of VLA-4 expression on circulating CD34+ cells.
    Yano T; Katayama Y; Sunami K; Ishimaru F; Shinagawa K; Ikeda K; Omoto E; Niiya K; Harada M
    Int J Hematol; 2000 Jun; 71(4):328-33. PubMed ID: 10905051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stem cell mobilization by granulocyte-colony-stimulating factor in acute myocardial infarction: lessons from the REVIVAL-2 trial.
    Zohlnhöfer D; Kastrati A; Schömig A
    Nat Clin Pract Cardiovasc Med; 2007 Feb; 4 Suppl 1():S106-9. PubMed ID: 17230206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GM-CSF-mobilized peripheral blood CD34+ cells differ from steady-state bone marrow CD34+ cells in adhesion molecule expression.
    Watanabe T; Dave B; Heimann DG; Lethaby E; Kessinger A; Talmadge JE
    Bone Marrow Transplant; 1997 Jun; 19(12):1175-81. PubMed ID: 9208110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: the MAGIC Cell-3-DES randomized, controlled trial.
    Kang HJ; Lee HY; Na SH; Chang SA; Park KW; Kim HK; Kim SY; Chang HJ; Lee W; Kang WJ; Koo BK; Kim YJ; Lee DS; Sohn DW; Han KS; Oh BH; Park YB; Kim HS
    Circulation; 2006 Jul; 114(1 Suppl):I145-51. PubMed ID: 16820564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pegylated granulocyte colony-stimulating factor mobilizes CD34+ cells with different stem and progenitor subsets and distinct functional properties in comparison with unconjugated granulocyte colony-stimulating factor.
    Bruns I; Steidl U; Fischer JC; Czibere A; Kobbe G; Raschke S; Singh R; Fenk R; Rosskopf M; Pechtel S; von Haeseler A; Wernet P; Tenen DG; Haas R; Kronenwett R
    Haematologica; 2008 Mar; 93(3):347-55. PubMed ID: 18268278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The alpha4beta1 and alpha5beta1 integrins mediate engraftment of granulocyte-colony-stimulating factor-mobilized human hematopoietic progenitor cells.
    Carstanjen D; Gross A; Kosova N; Fichtner I; Salama A
    Transfusion; 2005 Jul; 45(7):1192-200. PubMed ID: 15987366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Degradation of BM SDF-1 by MMP-9: the role in G-CSF-induced hematopoietic stem/progenitor cell mobilization.
    Jin F; Zhai Q; Qiu L; Meng H; Zou D; Wang Y; Li Q; Yu Z; Han J; Li Q; Zhou B
    Bone Marrow Transplant; 2008 Nov; 42(9):581-8. PubMed ID: 18679363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stem cell mobilization by granulocyte colony-stimulating factor for myocardial recovery after acute myocardial infarction: a meta-analysis.
    Zohlnhöfer D; Dibra A; Koppara T; de Waha A; Ripa RS; Kastrup J; Valgimigli M; Schömig A; Kastrati A
    J Am Coll Cardiol; 2008 Apr; 51(15):1429-37. PubMed ID: 18402895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of G-CSF on cardiac remodeling and arterial hyperplasia in rats.
    Li Y; Fukuda N; Yokoyama S; Kusumi Y; Hagikura K; Kawano T; Takayama T; Matsumoto T; Satomi A; Honye J; Mugishima H; Mitsumata M; Saito S
    Eur J Pharmacol; 2006 Nov; 549(1-3):98-106. PubMed ID: 16979158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced unique pattern of hematopoietic cell mobilization induced by the CXCR4 antagonist 4F-benzoyl-TN14003.
    Abraham M; Biyder K; Begin M; Wald H; Weiss ID; Galun E; Nagler A; Peled A
    Stem Cells; 2007 Sep; 25(9):2158-66. PubMed ID: 17525235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.